Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Novo Nordisk A/S
DescriptionCompound targeting triggering receptors expressed on myeloid cells 1 (TREM1)
Molecular Target Triggering receptor expressed on myeloid cells 1 (TREM1)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationSepsis
Indication DetailsTreat sepsis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today